Author

Angela Foulds

Observed names: A Foulds, A. Foulds, Abigail L. Foulds, Abigail Foulds

Institution: University of Pittsburgh

Observed institution: University of Pittsburgh

ORCID: 0009-0006-5361-1114

Observed ORCID: 0009-0006-5361-1114

OpenAlex ID: A5012242356

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

2022 · Laurent Peyrin-Biroulet, Laurent Peyrin-Biroulet, et al. · Clinical Gastroenterology and Hepatology · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): protocol for a randomised controlled trial

2025 · Abigail Foulds, Claire Josey, et al. · BMJ Open · 4

Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial

2025 · Philip S. Nash, Hakim-Moulay Dehbi, et al. · Stroke · 3

Economic evaluation of insulin glargine compared with human insulin for youth with type 1 diabetes in Tanzania and Bangladesh

2026 · Margaret L. Prust, Christina M. Lalama, et al. · PLoS ONE · 1

Systematic Discordance Between HbA1c and Continuous Glucose Monitoring-Derived Glycaemic Metrics in Paediatric Diabetes: Implications for Treatment Decisions

2025 · Ajmina Hasan Flabe, Jing Luo, et al. · Research Square · 1

Analogue vs human insulin for type 1 diabetes in low-resource settings: an explanatory qualitative study of HumAn1 trial

2025 · E. Ansbro, M. Marzouk, et al. · Diabetes Research and Clinical Practice

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Human Versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): A Multicenter, Open-Label, Randomised Controlled Trial

2025 · Jing Luo, Sylvia Kehlenbrink, et al. · SSRN Electronic Journal

Works count: 12

Citation count: 144

H-index: 5

I10-index: 4